It has been a long time coming, but the Philippine International Motor Show (PIMS) is making a return for the eighth installment for 2022. It’s no surprise automotive enthusiast are passionate and this is has been teased since mid-July that this car show will make its triumphant return this month.
Originally held every other year dating back to 2014, it has become one of the much awaited car shows in the Philippine automotive scene that features unveiling of the newest models and innovative technologies that separates itself from other car shows in the country. For this year is certainly is all about “Mobility + Humanity: Innovating for the Common Good” as its theme. |
Four year is a quite a long time from the last PIMS that happened, but the wait is finally over as the announcement for the event’s return has already been a buzz. The core of this event is the individual launch of the thirteen participating car manufacturers.
The list of participating automotive brands can be found below:
- Nissan
- Suzuki
- Foton
- Honda
- Kia
- Chery
- Geely
- Isuzu
- BMW
- Mitsubishi
- Hyundai
- Mazda
- Toyota
Besides the main event, which is the unveiling of the new models for each car manufacturers there will be activities and other announcements during the three day affair for everyone to participate and be part of.
This is definitely one of the best shows to happen since its last one in 2018, and definitely won’t be the last as emerging technologies continue to develop for better mobility and safety. The next best thing is yet to come, and the upcoming PIMS is true to its mission to bring everyone up to date on what’s next!
The 8th installment of the “Philippines International Motor Show” (PIMS) is happening on 15-18 September 2022 at the World Trade Center Metro Manila in Pasay City. Their Facebook Page’s URL changes every other year just search "Philippine International Motor Show" and it will take you to their page.
For more details about the event you can visit through CAMPI’s official site at: www.campiauto.org
No comments:
Post a Comment